BLASubcutaneousInjectablePriority Review
Approved
Dec 2024
Lifecycle
Growth
Competitive Pressure
30/100
Clinical Trials
9
Mechanism of Action
Tissue Factor Pathway Inhibitor Antagonists
Pharmacologic Class:
Tissue Factor Pathway Inhibitor Antagonist
Clinical Trials (5)
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
Started May 2025
30 enrolled
Haemophilia A, Haemophilia B
Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors
Started Aug 2024
23 enrolled
Haemophilia AHaemophilia B
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
Started Mar 2022
153 enrolled
Haemophilia A and B With and Without Inhibitors
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
Started Nov 2019
156 enrolled
Haemophilia A Without InhibitorsHaemophilia B Without Inhibitors
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
Started Oct 2019
134 enrolled
Haemophilia A With InhibitorsHaemophilia B With Inhibitors